Page 1962 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 113 Human Leukocyte Antigen and Human Neutrophil Antigen Systems 1737.e5

190. Hansen JA, Yamamoto K, Petersdorf E, et al: The role of HLA matching 211. Keilholz U, Weber J, Finke JH, et al: Immunologic monitoring of
in hematopoietic cell transplantation. Rev Immunogenet 1(3):359–373, cancer vaccine therapy: results of a workshop sponsored by the Society
1999. for Biological Therapy. J Immunother 25(2):97–138, 2002.
191. Barrett AJ: Mechanisms of the graft-versus-leukemia reaction. Stem Cells 212. Altman JD, Moss PA, Goulder PJ, et al: Phenotypic analysis of antigen-
15(4):248–258, 1997. specific T lymphocytes. Science 274(5284):94–96, 1996.
192. Kolb HJ, Mittermuller J, Clemm C, et al: Donor leukocyte transfusions 213. Monsurro VND Immunotracking of specific cancer vaccine CD lympho-
for treatment of recurrent chronic myelogenous leukemia in marrow cytes. 2003;Sect. 100.
transplant patients. Blood 76(12):2462–2465, 1990. 214. Boxer LA, Yokoyama M, Lalezari P: Isoimmune neonatal neutropenia.
193. Barrett AJ, Malkovska V: Graft-versus-leukaemia: understanding and J Pediatr 80(5):783–787, 1972.
using the alloimmune response to treat haematological malignancies. 215. Lalezari P, Bernard GE: An isologous antigen-antibody reaction with
Br J Haematol 93(4):754–761, 1996. human neutrophiles, related to neonatal neutropenia. J Clin Invest
194. Farag SS, Fehniger TA, Ruggeri L, et al: Natural killer cell receptors: 45(11):1741–1750, 1966.
new biology and insights into the graft-versus-leukemia effect. Blood 216. Bux J: Nomenclature of granulocyte alloantigens. ISBT Working
100(6):1935–1947, 2002. Party on Platelet and Granulocyte Serology, Granulocyte Antigen
195. de Bueger M, Bakker A, Van Rood JJ, et al: Tissue distribution of Working Party. International Society of Blood Transfusion. Transfusion
human minor histocompatibility antigens. Ubiquitous versus restricted 39(6):662–663, 1999.
tissue distribution indicates heterogeneity among human cytotoxic T 217. Trounstine ML, Peltz GA, Yssel H, et al: Reactivity of cloned, expressed
lymphocyte-defined non-MHC antigens. J Immunol 149(5):1788– human Fc gamma RIII isoforms with monoclonal antibodies which
1794, 1992. distinguish cell-type-specific and allelic forms of Fc gamma RIII. Int
196. Goulmy E: Human minor histocompatibility antigens. Curr Opin Immunol 2(4):303–310, 1990.
Immunol 8(1):75–81, 1996. 218. Ravetch JV, Perussia B: Alternative membrane forms of Fc gamma
197. Warren EH, Greenberg PD, Riddell SR: Cytotoxic T-lymphocyte- RIII(CD16) on human natural killer cells and neutrophils. Cell
defined human minor histocompatibility antigens with a restricted type-specific expression of two genes that differ in single nucleotide
tissue distribution. Blood 91(6):2197–2207, 1998. substitutions. J Exp Med 170(2):481–497, 1989.
198. Frahm N, Korber BT, Adams CM, et al: Consistent cytotoxic-T- 219. Ory PA, Clark MR, Kwoh EE, et al: Sequences of complementary
lymphocyte targeting of immunodominant regions in human immu- DNAs that encode the NA1 and NA2 forms of Fc receptor III on
nodeficiency virus across multiple ethnicities. J Virol 78(5):2187–2200, human neutrophils. J Clin Invest 84(5):1688–1691, 1989.
2004. 220. Huizinga TW, Kleijer M, Tetteroo PA, et al: Biallelic neutrophil
199. Meij P, Leen A, Rickinson AB, et al: Identification and prevalence of Na-antigen system is associated with a polymorphism on the phospho-
CD8(+) T-cell responses directed against Epstein-Barr virus-encoded inositol-linked Fc gamma receptor III (CD16). Blood 75(1):213–217,
latent membrane protein 1 and latent membrane protein 2. Int J Cancer 1990.
99(1):93–99, 2002. 221. Stroncek DF, Shankar R, Litz C, et al: The expression of the NB1
200. Provenzano M, Mocellin S, Bettinotti M, et al: Identification of immune antigen on myeloid precursors and neutrophils from children and
dominant cytomegalovirus epitopes using quantitative real-time poly- umbilical cords. Transfus Med 8(2):119–123, 1998.
merase chain reactions to measure interferon-gamma production by 222. Huizinga TW, de Haas M, Kleijer M, et al: Soluble Fc gamma receptor
peptide-stimulated peripheral blood mononuclear cells. J Immunother III in human plasma originates from release by neutrophils. J Clin Invest
25(4):342–351, 2002. 86(2):416–423, 1990.
201. Solache A, Morgan CL, Dodi AI, et al: Identification of three HLA- 223. Bux J, Stein EL, Bierling P, et al: Characterization of a new alloan-
A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus tigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood
protein pp65 that are conserved between eight strains of the virus. J 89(3):1027–1034, 1997.
Immunol 163(10):5512–5518, 1999. 224. Bux J, Stein EL, Santoso S, et al: NA gene frequencies in the German
202. Rosenberg SA: Progress in human tumour immunology and immuno- population, determined by polymerase chain reaction with sequence-
therapy. Nature 411(6835):380–384, 2001. specific primers. Transfusion 35(1):54–57, 1995.
203. Lee KH, Wang E, Nielsen MB, et al: Increased vaccine-specific T cell 225. Hessner MJ, Curtis BR, Endean DJ, et al: Determination of neutrophil
frequency after peptide-based vaccination correlates with increased antigen gene frequencies in five ethnic groups by polymerase chain
susceptibility to in vitro stimulation but does not lead to tumor regres- reaction with sequence-specific primers. Transfusion 36(10):895–899,
sion. J Immunol 163(11):6292–6300, 1999. 1996.
204. Lin CL, Lo WF, Lee TH, et al: Immunization with Epstein-Barr Virus 226. Lin M, Chen CC, Wang CL, et al: Frequencies of neutrophil-specific
(EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell antigens among Chinese in Taiwan. Vox Sang 66(3):247, 1994.
immunity and may lead to tumor regression in patients with EBV- 227. Matsuo K, Procter J, Stroncek D: Variations in genes encoding neutro-
positive nasopharyngeal carcinoma. Cancer Res 62(23):6952–6958, phil antigens NA1 and NA2. Transfusion 40(6):645–653, 2000.
2002. 228. Ohto H, Matsuo Y: Neutrophil-specific antigens and gene frequencies
205. Parmiani G, Castelli C, Dalerba P, et al: Cancer immunotherapy with in Japanese. Transfusion 29(7):654, 1989.
peptide-based vaccines: what have we achieved? Where are we going? J 229. Kissel K, Hofmann C, Gittinger FS, et al: HNA-1a, HNA-1b, and
Natl Cancer Inst 94(11):805–818, 2002. HNA-1c (NA1, NA2, SH) frequencies in African and American Blacks
206. Monsurro V, Nagorsen D, Wang E, et al: Functional heterogeneity and in Chinese. Tissue Antigens 56(2):143–148, 2000.
of vaccine-induced CD8(+) T cells. J Immunol 168(11):5933–5942, 230. Koene HR, Kleijer M, Roos D, et al: Fc gamma RIIIB gene duplica-
2002. tion: evidence for presence and expression of three distinct Fc gamma
207. Einsele H, Roosnek E, Rufer N, et al: Infusion of cytomegalovirus RIIIB genes in NA(1+,2+)SH(+) individuals. Blood 91(2):673–679,
(CMV)-specific T cells for the treatment of CMV infection not 1998.
responding to antiviral chemotherapy. Blood 99(11):3916–3922, 2002. 231. Reil A, Sachs UJ, Siahanidou T, et al: HNA-1d: a new human neutro-
208. Green M: Management of Epstein-Barr virus-induced post-transplant phil antigen located on Fcgamma receptor IIIb associated with neonatal
lymphoproliferative disease in recipients of solid organ transplantation. immune neutropenia. Transfusion 53(10):2145–2151, 2013.
Am J Transplant 1(2):103–108, 2001. 232. de Haas M, Kleijer M, van Zwieten R, et al: Neutrophil Fc gamma
209. Dudley ME, Wunderlich JR, Robbins PF, et al: Cancer regression and RIIIb deficiency, nature, and clinical consequences: a study of 21
autoimmunity in patients after clonal repopulation with antitumor individuals from 14 families. Blood 86(6):2403–2413, 1995.
lymphocytes. Science 298(5594):850–854, 2002. 233. Fromont P, Bettaieb A, Skouri H, et al: Frequency of the polymor-
210. Sznol MMF: Principles of immune monitoring in cancer vaccine trials. phonuclear neutrophil Fc gamma receptor III deficiency in the French
In Rosenberg SA, editor: Principles and practice of the biologic therapy of population and its involvement in the development of neonatal alloim-
cancer, 2000, Lippincott Williams & Wilkins. mune neutropenia. Blood 79(8):2131–2134, 1992.